COMPUMEDICS LIMITED — Capital/Financing Update 2014

Apr 8, 2014

==> picture [74 x 64] intentionally omitted <==

ASX Announcement 9 April 2014

**MAJOR

CONTRACT WIN IN THE US GIVES COMPUMEDICS ACCESS TO 1,400 HOSPITALS**

Highlights:

• Compumedics signs 3-­‐year agreement with HealthTrust Purchasing Group as a preferred vendor for the purchase of sleep diagnostic and neuro-­‐monitoring systems to their member group

• HealthTrust membership comprises nearly 1,400 hospitals and 10,600 non-­‐acute healthcare facilities across America

Compumedics Limited (ASX: CMP) is pleased to announce that its wholly owned subsidiary, Compumedics USA, Inc. has won a 3-­‐year agreement with HealthTrust Purchasing Group (“HealthTrust”) for the purchase of Compumedics sleep diagnostic and neuro-­‐monitoring systems. Under this agreement HealthTrust will provide its members with access to purchase Compumedics’ range of sleep diagnostic and neuro-­‐monitoring systems.

The HealthTrust member network consists of 1,400 hospitals and 10,600 non-­‐acute healthcare facilities across America. Compumedics is one of only two vendors that have been given preferred vendor status for sleep diagnostic and neuro-­‐monitoring systems to the HealthTrust Purchasing Group.

For more than 25 years, health care providers worldwide have chosen Compumedics’ comprehensive and innovative line of sleep diagnostic and neuro–monitoring systems to aid in the diagnosis, information and treatment of their patients. The HealthTrust contract confirms the enduring nature of Compumedics proposition to deliver innovative solutions to market.

Compumedics remains highly focused on growing the Group through:

• Expansion of the Company’s existing products to all key global markets;

• Expansion of sales of the Company’s existing products into emerging markets, particularly China; and

• Continuing the initial penetration of the neuro-­‐diagnostic market, particularly the US, with Compumedics’ range of neuro-­‐diagnostic products, including the Neuvo ® LTEM (long-­‐term EEG-­‐monitoring) system

In commenting on this new deal for the Company, Executive Chairman & CEO, Dr David Burton said: “We are delighted to announce another substantial contract win for Compumedics. HealthTrust Purchasing Group is one of the major member networks for hospitals in the US market and to sign a 3-­‐year agreement with them, giving access to 1,400 hospitals is a significant milestone achievement for our Company.”

==> picture [74 x 64] intentionally omitted <==

**ABOUT

COMPUMEDICS**

Compumedics Limited was founded in 1987 by current Chairman/CEO Dr. David Burton and today is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In 1995 the company was selected to supply equipment to the U.S. Sleep Heart Health Study, the world's largest sleep study of its kind, with over 8,000 participants scheduled by 2008. In 1998 Compumedics was awarded the overall Australian Exporter of the Year. In 2000 Compumedics was listed on the Australian Stock Exchange. In 2002 , Compumedics acquired U.S.-­‐based Neuroscan —the world's leading supplier of instruments for brain research. In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy. In 2004 , Compumedics acquired Germany-­‐based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-­‐vascular diagnostic fields. In 2006 , Compumedics was awarded the Frost and Sullivan Technology Leadership award for its innovative Somte® recorder product. In 2007 , Compumedics and its Chairman were inducted into the Victorian Manufacturing Hall of Fame. In 2008 the DWL division received a top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics Compumedics sales have grown more than 4-­‐fold from $9 million (1999) to $39 million (2008). In 2009 Compumedics was awarded a design award for its GRAEL® PSG/EEG premium laboratory-­‐based product. In 2010 Compumedics was recognized by the Australian Innovation Government and Industry body as one of Australia's Top 100 Health Innovators through its world leading devices for sleep diagnostics. In 2011, Compumedics was chosen, as one of only 25, innovative Australian companies by the Australian Governments Department of Innovation, Industry, Science and Research (Industry). In 2012 Compumedics won several key-­‐opinion-­‐leader sites for the installation of it newly released long-­‐term EEG monitoring (LTEM) equipment. In 2013 the Company refinanced the Group to better facilitate its on-­‐going business operations. This included an equity issue to Beijing Bestmed, it long-­‐term partner in China.

**ABOUT

HEALTHTRUST**

HealthTrust (legally known as HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total cost management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com) serves nearly 1,400 acute care facilities, 800 ambulatory surgery centers and members in more than 10,600 other locations, including physician practices, long-­‐ term care and alternate care sites. Headquartered in Brentwood, Tenn., HealthTrust is closely integrated with the proven capabilities of Parallon (www.parallon.com), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions.

**For

further information please contact:**

Dr David Burton , Executive Chairman, CEO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399

Mr David Lawson , Executive Director, CFO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399

**For

investor relations and media enquiries please contact:**

Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunications.com.au